Synapse - Catherine O'Connor

Results (19)

Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: Clinical insights and genomic features from a large contemporary cohort

Journal Article

Keane, F.; O’Connor, C.; Moss, D.; Chou, J. F.; Perry, M. A.; Crowley, F.; Saxena, P.; Chan, A.; Schoenfeld, J. D.; Singhal, A.; more...
JNCI: Journal of the National Cancer Institute (2025)

Fulltext@MSK | Save

Phase II trial of Pembrolizumab and OLApaRib (POLAR) maintenance for select patients (pts) with metastatic pancreatic cancer (mPC) with (A) homologous recombination deficiency (HRD), (B) non-core HRD (ncHRD) and (C) exceptional response to platinum

Meeting Abstract

Park, W.; O'Connor, C.; Chou, J.; Schwartz, C.; Larsen, M.; Varghese, A.; Yu, K.; Balogun, F.; Yang, J.; Katz, S.; more...
Annals of Oncology (2024)

Fulltext@MSK | Save

Lynch syndrome and somatic mismatch repair variants in pancreas cancer

Journal Article

O'Connor, C. A.; Harrold, E.; Lin, D.; Walch, H.; Gazzo, A.; Ranganathan, M.; Kane, S.; Keane, F.; Schoenfeld, J.; Moss, D.; more...
JAMA Oncology (2024)

Fulltext@MSK | Save

Precision medicine for pancreatic cancer: Characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease

Journal Article

Keane, F.; Chou, J. F.; Walch, H.; Schoenfeld, J.; Singhal, A.; Cowzer, D.; Harrold, E.; O'Connor, C. A.; Park, W.; Varghese, A.; more...
JNCI: Journal of the National Cancer Institute (2024)

Fulltext@MSK | Save

Durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and borderline resectable (BR) pancreatic cancer (PDAC): Long-term outcomes and correlative insights

Meeting Abstract

Keane, F.; Tuli, R.; O'Connor, C. A.; Schwartz, C.; Park, W.; Varghese, A. M.; Perry, M.; Singhal, A.; Vardhana, S.; Hendifar, A. E.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Adjuvant mFOLFIRINOX (mFFX) for resected pancreatic cancer (PC): Long term clinical and genomic outcomes

Meeting Abstract

Keane, F.; Moss, D.; O'Connor, C. A.; Perry, M.; Chou, J. F.; Crowley, F.; Saxena, P.; Chan, A.; Park, W.; Varghese, A. M.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Somatic mismatch repair deficiency in pancreas cancer (PC): Immune checkpoint blockade (ICB) outcomes and exploratory genomic analyses

Meeting Abstract

O'Connor, C. A.; Harrold, E.; Lin, Y. T.; Walch, H. S.; Gazzo, A.; Kane, S. R.; Keane, F.; Schoenfeld, J. D.; Moss, D.; Suehnholz, S. P.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Clinical and molecular characterization of microsatellite stable (MSS) tumors in patients with Lynch syndrome (LS)

Meeting Abstract

Harrold, E.; Vanderbilt, C.; Maio, A.; Borio, M.; Ranganathan, M.; Sheehan, M.; O'Connor, C.; Murciano-Goroff, Y. R.; Walsh, M. F.; Will, M.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

A phase I/II study of durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and borderline resectable (BR) pancreatic cancer